Cigna Aktie News

Cigna plans to make close copies of AbbVie's blockbuster arthritis drug Humira available with no out-of-pocket payment to eligible patients in the U.S. using its specialty pharmacy beginning in June, the health insurer said on Thursday.

High- and low-concentration interchangeable biosimilar will be available, estimated to save individual patients around $3,500 on average per year  Biosimilar price will be about 85% lower than Humira®* BLOOMFIELD, Conn. , April 25, 2024 /PRNewswire/ -- In an important step toward driving long-term affordability and access to treatments for chronic and complex conditions, Evernorth Health Servic...

BLOOMFIELD, Conn. , April 24, 2024 /PRNewswire/ -- The Board of Directors of The Cigna Group (NYSE: CI) today declared a cash dividend of $1.40 per share of its common stock, payable on June 20, 2024 to shareholders of record as of the close of business on June 4, 2024.

Over the years, the healthcare industry in the United States has morphed into a complex web of insurance companies, hospital corporations and medical providers. Since the 2020 Coronavirus pandemic, U.S. healthcare spending and government subsidization have ballooned to nearly double pre-pandemic levels.

The Federal Trade Commission is working to accelerate its inquiry into the prescription-drug middlemen known as pharmacy-benefit managers, while also expanding its scrutiny of drug patents that can keep prescription prices artificially high, FTC Chair Lina Khan told reporters Tuesday.

BLOOMFIELD, Conn. , April 23, 2024 /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) announced today that Brian Evanko, executive vice president and chief financial officer, will present at the BofA Securities 2024 Health Care Conference on May 15, 2024, in Las Vegas, NV.

Healthcare stocks, especially industry leaders that offer a wide range of products and services, can be an investor's best friend due to the growing need for increased development of healthcare products and services. These stocks tend to provide investors with a substantial return on their investment.

This article focuses on selecting high-growth dividend stocks that have rapidly grown their dividends in the recent past, rather than simply sport a high current yield. We use our proprietary models to rate quantitatively and qualitatively and select the top ten names from an initial list of nearly 400 dividend stocks. The article provides criteria for selecting high-growth dividend stocks. It ...